ES8402811A1 - Procedimientos para preparar derivados de tretalina. - Google Patents

Procedimientos para preparar derivados de tretalina.

Info

Publication number
ES8402811A1
ES8402811A1 ES515722A ES515722A ES8402811A1 ES 8402811 A1 ES8402811 A1 ES 8402811A1 ES 515722 A ES515722 A ES 515722A ES 515722 A ES515722 A ES 515722A ES 8402811 A1 ES8402811 A1 ES 8402811A1
Authority
ES
Spain
Prior art keywords
compounds
stands
radical
amino
halogenoalkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515722A
Other languages
English (en)
Other versions
ES515722A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES8402811A1 publication Critical patent/ES8402811A1/es
Publication of ES515722A0 publication Critical patent/ES515722A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE TETRALINA, DE FORMULA GENERAL (I).CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II), EN LA QUE R3, R4 Y N TIENEN LOS SIGNIFICADOS YA INDICADOS, CON UN COMPUESTO DE FORMULA: R5Z, EN LA QUE R5 ES UN RADICAL ALQUILO, ALQUENILO O ALQUINILO; Y Z ES UN ATOMO DE HALOGENO, EN PRESENCIA DE UN AGENTE ACEPTOR DE ACIDO.DE APLICACION COMO AGENTES ANALGESICOS POTENCIALES.
ES515722A 1981-09-15 1982-09-15 Procedimientos para preparar derivados de tretalina. Granted ES515722A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8127869 1981-09-15

Publications (2)

Publication Number Publication Date
ES8402811A1 true ES8402811A1 (es) 1984-03-01
ES515722A0 ES515722A0 (es) 1984-03-01

Family

ID=10524524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515722A Granted ES515722A0 (es) 1981-09-15 1982-09-15 Procedimientos para preparar derivados de tretalina.

Country Status (13)

Country Link
US (1) US4464358A (es)
EP (1) EP0077122B1 (es)
JP (1) JPS5869852A (es)
AT (1) ATE19621T1 (es)
AU (1) AU566342B2 (es)
CA (1) CA1257746A (es)
DE (1) DE3271003D1 (es)
ES (1) ES515722A0 (es)
GR (1) GR78055B (es)
IE (1) IE53715B1 (es)
IL (1) IL66789A (es)
NZ (1) NZ201914A (es)
ZA (1) ZA826296B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684624A (en) * 1983-12-22 1987-08-04 Yoshio Hosobuchi Method of treating cerebral ischemia
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US6407061B1 (en) * 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
AU1106195A (en) * 1994-11-09 1996-06-06 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
AU5667900A (en) 1999-06-30 2001-01-22 Prescient Neuropharma Inc. 2-aminoindane analogs
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
JP2008514612A (ja) * 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
JPS5869852A (ja) 1983-04-26
IE822042L (en) 1983-03-15
NZ201914A (en) 1986-01-24
ATE19621T1 (de) 1986-05-15
EP0077122A3 (en) 1984-06-27
EP0077122B1 (en) 1986-05-07
IL66789A (en) 1985-09-29
CA1257746A (en) 1989-07-18
IE53715B1 (en) 1989-01-18
ES515722A0 (es) 1984-03-01
EP0077122A2 (en) 1983-04-20
US4464358A (en) 1984-08-07
DE3271003D1 (en) 1986-06-12
ZA826296B (en) 1983-08-31
AU566342B2 (en) 1987-10-15
AU8801482A (en) 1983-03-24
GR78055B (es) 1984-09-26

Similar Documents

Publication Publication Date Title
ES8402811A1 (es) Procedimientos para preparar derivados de tretalina.
IL86381A0 (en) Oxetanocins and pharmaceutical compositions containing the same
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
HU9402218D0 (en) Pyridinecarboximidamide compounds, pharmaceutical compositions containing them and process for producing them
PT79839B (en) Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
EP0281412A3 (en) Novel organic platinum complex pharmaceutical compositions containing same and a process for the preparation thereof
ES8705410A1 (es) Un procedimiento para preparar un derivado de 1,5 beurotiarepina.
JPS57212148A (en) Aminoacyl derivative and opiate receptor antagonistic pharmaceutical composition containing same
DE3269533D1 (en) New quinolylacetic acid compounds and pharmaceutical compositions containing them
GB1473971A (en) 3-hydroxy-5,6-benzomorphinan derivatives
ES8500742A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
DE3665593D1 (en) Peptide immunostimulants
ES2000369A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
ES476273A1 (es) Un procedimiento para preparar nuevos analogos de cefalospo-rina
ES8603871A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
DE3763704D1 (de) Syndetseife.
GB1492361A (en) Optically active m-acyloxy-alpha(methylamino)methyl)-benzyl alcohols the pharmaceutically acceptable acid addition salts thereof and synthesis of same
ES8307712A1 (es) "procedimiento para la preparacion de n-(2,6-diclorofenil)-acetamidina".
ES8502094A1 (es) Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina.
JPS56108723A (en) Preparation of indene derivative
GB1465616A (en) Pyridoxamine derivatives